Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: The Brigham and Women's Hospital DVT registry

American Heart Journal

Volumn 132, Issue 5, 1996, Pages 1010-1014

  Piccioli, Andrea ^a   Prandoni, Paolo ^a   Goldhaber, Samuel Z ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURGICAL PATIENT;

EID: 0029807723     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90014-9     Document Type: Article

References (15)

1. Gustafson TL. True Epistat reference manual. Richardson, (TX): Epistat Services, 1994.
2. Epi Info version 1.01b. Atlanta: Centers for Disease Control, Epidemiology Office, 1991.
3. Nordström N, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992;232:155-60.
4. Kniffin WD, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861-6.
5. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995; 274:335-7.
6. Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, Simioni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994;154:164-8.
7. Becker DM, Philbrick JT, Selby JB. Inferior vena cava filters: indications, safety, effectiveness. Arch Intern Med 1992;152:1985-94.
8. Goldhaber SZ. Contemporary pulmonary embolism thombolysis. Chest 1995;107:45S-51S.
9. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76:393-7.
10. Brown WD, Goldhaber SZ. How to select patients with deep vein thrombosis for tPA therapy. Chest 1989;95:276S-8S.
11. Markel A, Manzo RA, Strandness E Jr. The potential role of thrombolytic therapy in venous thrombosis. Arch Intern Med 1992; 152: 1265-7.
12. Levine M, Raskob GE, Landefeld CS, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108:276S-90S.
13. Leizorovicz A, Simonneau G, Decousus H, Boissel JP. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a metaanalysis. BMJ Br Med J 1994;309:299-305.
14. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med 1991; 151:933-8.
15. Goldhaber SZ, Visani L, The International Cooperative Pulmonary Embolism Registry. Chest 1995;108:302-4.